Cardiac Myosin Activation in the Treatment of Congestive Heart Failure: New Therapeutic Options and Review of Literature

Congestive heart failure (HF) remains a major cause of cardiac-related morbidity and mortality, despite major therapeutic advancements. A newer class of medications has recently been developed which targets the root cause of HF, which is reduced myocardial contractility. This article aims to highlig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Arroj, Abdelmaseih, Ramy, Thakker, Ravi, Faluk, Mohammed, Hasan, Syed Mustajab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939388/
https://www.ncbi.nlm.nih.gov/pubmed/35330650
http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_39_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939388/
https://www.ncbi.nlm.nih.gov/pubmed/35330650
http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_39_21

Ejemplares similares